Status:
COMPLETED
Forxiga Tablets Specific Clinical Experience Investigation for Elderly
Lead Sponsor:
AstraZeneca
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
Brief Summary
The purpose of the investigation is to confirm the following under the post-marketing actual use of Forxiga Tablets (hereinafter referred to as Forxiga) in elderly patients. * Development of ADRs spe...
Eligibility Criteria
Inclusion
- Patients treated with Forxiga for the first time during three months after the launch due to type 2 diabetes mellitus, which is the indication of the drug, aged 65 or over at the time when Forxiga was started.
- In addition, patients receiving the study drug of Forxiga before the launch should be included also.
Exclusion
- N/A
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
1724 Patients enrolled
Trial Details
Trial ID
NCT02200627
Start Date
September 1 2014
End Date
April 1 2016
Last Update
February 23 2017
Active Locations (46)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aichi, Japan
2
Research Site
Akita, Japan
3
Research Site
Aomori, Japan
4
Research Site
Chiba, Japan